ORKA
Oruka Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Oruka Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $862.0M | 12.16% | +21.88% | |
| 2 | BlackRockBlackRockindex-like | $474.9M | 6.70% | +41.48% | |
| 3 | VR AdviserVR Adviser | $394.8M | 5.57% | 0.00% | |
| 4 | Fairmount Funds ManagementFairmount Funds | $352.6M | 4.98% | 0.00% | |
| 5 | Capital World InvestorsCapital World Investors | $323.7M | 4.57% | new | |
| 6 | RTW InvestmentsRTW | $298.7M | 4.22% | +52.52% | |
| 7 | State StreetState Streetindex-like | $254.4M | 3.59% | +65.67% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $224.7M | 3.17% | +26.96% | |
| 9 | Paradigm Biocapital AdvisorsParadigm Biocapital | $204.1M | 2.88% | −7.58% | |
| 10 | Deep Track CapitalDeep Track Capital | $183.3M | 2.59% | −5.32% | |
| 11 | Bellevue GroupBellevue | $157.7M | 2.23% | +226.86% | |
| 12 | Franklin ResourcesFranklin Resources | $154.3M | 2.18% | +61.49% | |
| 13 | Remedium Capital PartnersRemedium Capital Partners | $149.0M | 2.10% | −17.12% | |
| 14 | RA Capital ManagementRA Capital Management | $148.0M | 2.09% | new | |
| 15 | Viking Global InvestorsViking Global Investors | $143.1M | 2.02% | −43.62% | |
| 16 | Geode Capital ManagementGeodeindex-like | $136.1M | 1.92% | +49.75% | |
| 17 | Jupiter TopcoJupiter Topco | $131.0M | 1.85% | — | |
| 18 | Perceptive AdvisorsPerceptive | $128.0M | 1.81% | −3.61% | |
| 19 | Polar Capital HoldingsPolar Capital | $116.9M | 1.65% | +17.27% | |
| 20 | Citadel AdvisorsCitadel | $109.7M | 1.55% | +13.16% | |
| 21 | T. Rowe Price Investment ManagementT. Rowe Price | $105.0M | 1.48% | new | |
| 22 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $102.7M | 1.45% | +9773.86% | |
| 23 | T. Rowe Price AssociatesT. Rowe Price | $79.8M | 1.13% | +15.28% | |
| 24 | Avidity Partners ManagementAvidity Partners | $72.4M | 1.02% | 0.00% | |
| 25 | Summit Partners Public Asset ManagementSummit Partners Public | $62.7M | 0.88% | new |
Fund move
No thesis.
Oruka Therapeutics, Inc.
98.76
256 managers report $7.1B of Oruka Therapeutics on form 13F for the quarter ended Jun 30 '26. 30 of them hold 80% of it; FMR is largest at 12.16%.
Expected move
Inputsspot 96.87exp Nov 20ATM strike 95ATM straddle 10.58IV 54%